| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |